Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PRA
PRA logo

PRA Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Proassurance Corp (PRA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
24.630
1 Day change
0.16%
52 Week Range
24.850
Analysis Updated At
2026/04/10
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Proassurance Corp (PRA) is not a strong buy for a beginner, long-term investor at the moment. The lack of significant positive trading signals, neutral trading trends, and weak technical indicators suggest that the stock does not present an immediate buying opportunity. Additionally, while the company's net income and EPS have shown strong growth in the latest quarter, the revenue decline and lack of positive catalysts make this stock less appealing for long-term investment at this time.

Technical Analysis

The technical indicators for PRA are weak. The MACD histogram is negative and expanding, indicating bearish momentum. RSI is in the neutral zone at 29.584, and moving averages are converging, suggesting no clear trend. The stock is trading near its support level (S1: 24.205), but there is no strong indication of a reversal or breakout.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
6

Positive Catalysts

  • The company's net income and EPS have shown significant YoY growth, with net income up 106.38% and EPS up 106.45% in 2025/Q4.

Neutral/Negative Catalysts

  • Revenue declined by -5.54% YoY in the latest quarter. No recent news or significant trading trends from hedge funds or insiders. Technical indicators suggest bearish momentum, and stock trend analysis predicts a slight decline in the short term.

Financial Performance

In 2025/Q4, Proassurance Corp's revenue dropped to $272.95M (-5.54% YoY). However, net income increased to $33.37M (+106.38% YoY), and EPS rose to 0.64 (+106.45% YoY). Gross margin remained unchanged.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst rating or price target changes were provided for PRA.

Wall Street analysts forecast PRA stock price to rise
Analyst Rating
0
Wall Street analysts forecast PRA stock price to rise
Buy
Hold
Sell
0
Current: 24.630
sliders
Low
0
Averages
0
High
0
0
Current: 24.630
sliders
Low
0
Averages
0
High
0
Piper Sandler
Paul Newsome
Neutral
maintain
$18 -> $25
AI Analysis
2025-05-08
Reason
Piper Sandler
Paul Newsome
Price Target
$18 -> $25
AI Analysis
2025-05-08
maintain
Neutral
Reason
Piper Sandler analyst Paul Newsome raised the firm's price target on ProAssurance to $25 from $18 and keeps a Neutral rating on the shares. The firm notes the company reported a miss versus PSC and consensus. Underwriting results were worse than expected, but top-line results were higher than Piper expected and premiums in the company's medical malpractice business were stable. Bottom-line results were impacted by non-operating items totaling $12.6M related to its merger with The Doctors Company, the firm adds.

People Also Watch